1. Home
  2. FBIZ vs MYGN Comparison

FBIZ vs MYGN Comparison

Compare FBIZ & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Business Financial Services Inc.

FBIZ

First Business Financial Services Inc.

HOLD

Current Price

$55.74

Market Cap

488.9M

Sector

Finance

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.79

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIZ
MYGN
Founded
1909
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
488.9M
444.2M
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
FBIZ
MYGN
Price
$55.74
$4.79
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$65.00
$7.64
AVG Volume (30 Days)
40.3K
1.0M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
2.37%
N/A
EPS Growth
14.23
N/A
EPS
5.94
N/A
Revenue
N/A
$771,400,000.00
Revenue This Year
$15.69
$6.86
Revenue Next Year
$8.47
$5.45
P/E Ratio
$9.67
N/A
Revenue Growth
N/A
2.33
52 Week Low
$45.90
$3.76
52 Week High
$60.54
$8.59

Technical Indicators

Market Signals
Indicator
FBIZ
MYGN
Relative Strength Index (RSI) 46.02 48.86
Support Level $53.56 $4.25
Resistance Level $59.76 $5.52
Average True Range (ATR) 1.36 0.30
MACD -0.20 0.02
Stochastic Oscillator 20.26 45.24

Price Performance

Historical Comparison
FBIZ
MYGN

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products, including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically, all the business activity functioned through the region of the United States.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: